Amicus Therapeutics Future Growth
Future criteria checks 5/6
Amicus Therapeutics is forecast to grow earnings and revenue by 61.4% and 24.3% per annum respectively while EPS is expected to grow by 59% per annum.
Key information
61.4%
Earnings growth rate
59.0%
EPS growth rate
| Biotechs earnings growth | 0% |
| Revenue growth rate | 24.3% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 24 Apr 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 750 | 183 | 175 | 166 | 6 |
| 12/31/2024 | 564 | 60 | 65 | 88 | 11 |
| 12/31/2023 | 393 | -111 | -69 | -66 | 12 |
| 12/31/2022 | 329 | -237 | -170 | -167 | N/A |
| 9/30/2022 | 323 | -264 | -159 | -156 | N/A |
| 6/30/2022 | 321 | -281 | -172 | -168 | N/A |
| 3/31/2022 | 318 | -270 | -192 | -188 | N/A |
| 12/31/2021 | 306 | -250 | -206 | -202 | N/A |
| 9/30/2021 | 294 | -239 | -185 | -182 | N/A |
| 6/30/2021 | 282 | -252 | -203 | -200 | N/A |
| 3/31/2021 | 267 | -254 | -201 | -198 | N/A |
| 12/31/2020 | 261 | -277 | -237 | -233 | N/A |
| 9/30/2020 | 246 | -295 | -254 | -241 | N/A |
| 6/30/2020 | 227 | -293 | -272 | -255 | N/A |
| 3/31/2020 | 209 | -325 | -298 | -280 | N/A |
| 12/31/2019 | 182 | -356 | -270 | -250 | N/A |
| 9/30/2019 | 160 | -345 | -264 | -253 | N/A |
| 6/30/2019 | 131 | -442 | -340 | -330 | N/A |
| 3/31/2019 | 109 | -419 | -337 | -329 | N/A |
| 12/31/2018 | 91 | -349 | -306 | -300 | N/A |
| 9/30/2018 | 73 | -340 | -318 | -312 | N/A |
| 6/30/2018 | 64 | -293 | -233 | -228 | N/A |
| 3/31/2018 | 49 | -279 | -218 | -213 | N/A |
| 12/31/2017 | 37 | -284 | -218 | -214 | N/A |
| 9/30/2017 | 25 | -273 | -176 | -173 | N/A |
| 6/30/2017 | 16 | -208 | -168 | -165 | N/A |
| 3/31/2017 | 9 | -211 | -159 | -155 | N/A |
| 12/31/2016 | 5 | -200 | -156 | -150 | N/A |
| 9/30/2016 | 2 | -184 | N/A | -154 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FOLD * is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (7.5%).
Earnings vs Market: FOLD * is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: FOLD * is expected to become profitable in the next 3 years.
Revenue vs Market: FOLD *'s revenue (24.3% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: FOLD *'s revenue (24.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FOLD *'s Return on Equity is forecast to be high in 3 years time